2017 / 06

DOI: 10.24075/brsmu.2017-06-12

ORIGINAL RESEARCH

Temporal dynamics of cytokines in the blood of rats with experimentally induced autoimmune encephalomyelitis

Pozdniakova NV1, Turobov VI2, Garanina EE3, Ryabaya OA1, Biryukova YuK4, Minkevich NI2, Trubnikova EV5, Shevelev AB6, Kuznetsova TV7, Belyakova AV4, Udovichenko IP2,8
About authors

1 Blokhin National Medical Research Center of Oncology, Moscow

2 Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Pushchino branch, Russia

3 Кazan (Volga Region) Federal University, Kazan, Russia

4 Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow

5 Kursk State University, Kursk

6 Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences, Moscow, Russia

7 Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia

8 Pushchino State Institute of Natural Sciences, Pushchino, Russia

Correspondence should be addressed: Igor Udovichenko
Pr-t Nauki, d. 6, Puschino, Moscow oblast, Russia, 142290; ur.xednay@1oknehcivodui

About paper

Funding: this work was supported by the Ministry of Education and Science of the Russian Federation (Grant agreement 14.607.21.0133 dated October 27, 2015, ID RFMEFI60715X0133).

Acknowledgements: the authors thank Boris Shevelev for help in immunization of the animals.

All authors' contribution to this work is equal: selection and analysis of literature, research planning, data collection, analysis, and interpretation, drafting of a manuscript, editing.

Received: 2017-12-15 Accepted: 2017-12-20 Published online: 2018-01-25
|
  1. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology. 2002 Jan 8; 58 (1): 136–8.
  2. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000 Jun; 47 (6): 707–17.
  3. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 Jul; 50 (1): 121–7.
  4. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: are-evaluation. Brain. 1999 Oct; 122 (Pt 10): 1941–50.
  5. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000 Nov 16; 343 (20): 1430–8. DOI: 10.1056/NEJM200011163432001.
  6. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989 Feb; 112 (Pt 1): 133–46.
  7. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 May; 132 (Pt 5): 1175–89. DOI: 10.1093/brain/awp070.
  8. Mensah-Brown EP, Shahin A, Garey LJ, Lukic ML. Neuroglial response after induction of experimental allergic encephalomyelitis insusceptible and resistant rat strains. Cell Immunol. 2005 Feb; 233 (2): 140–7. DOI: 10.1016/j.cellimm.2005.04.023.
  9. Contarini G, Giusti P, Skaper SD. Active Induction of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice. Methods Mol Biol. 2018; 1727: 353–60. DOI: 10.1007/978-1-4939-7571-6_26.
  10. Khaibullin T, Ivanova V, Martynova E, Cherepnev G, Khabirov F, Granatov E et al. Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients. Front Immunol. 2017 May 18; 8: 531. DOI: 10.3389/fimmu.2017.00531.
  11. Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol. 2000; 115(1): 81–7.
  12. Beeton C, Garcia A, Chandy KG. Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis. J Vis Exp. 2007; (5): 224. DOI: 10.3791/224.
  13. Poveschenko AF, Kazakov OV, Orlov NB, Poveschenko OV, Kim II, Bondarenko NA et al. [Serum cytokines of Wistar rats — markers of carcinogenesisand effectiveness of cancer therapy]. Fundamental research. 2015; 1 (Pt 8): 1664–70. Russian.
  14. Hamblin AS. Lymphokines and interleukins. Immunology. 1988; 64 (Suppl 1): 39–41.